Company intelligence / Profile preview

Narya

Boston, MA, USA

Ownership: Private
Development stage: Other

Overview

Narya is a skin longevity company co-founded by Dr. David Sinclair, a prominent Harvard geneticist and aging researcher. The company focuses on translating cellular longevity science into advanced skincare solutions that target the root causes of skin aging rather than just the symptoms. Narya's products are designed to support mitochondrial health, boost NAD+ levels, and activate sirtuins to promote cellular rejuvenation and extend the healthspan of the skin. Their flagship offering is a high-performance serum that utilizes a proprietary complex to improve skin resilience, texture, and overall vitality.

Therapeutic areas: Dermatology
Modalities: Small moleculePeptides
Industry: Food & Nutrition

Beyond the preview

Go deeper on Narya.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Narya.

Explore the full profile